Headache News and Research

Latest Headache News and Research

First generic versions of Aciphex delayed-release tablets get FDA approval for GERD treatment

The U.S. Food and Drug Administration today approved the first generic versions of Aciphex (rabeprazole sodium) delayed-release tablets, used to treat gastroesophageal reflux disease in adults and adolescents (ages 12 and up).

10 Nov 2013

Aptiom receives FDA approval to treat seizures associated with epilepsy

The U.S. Food and Drug Administration today approved Aptiom (eslicarbazepine acetate) as an add-on medication to treat seizures associated with epilepsy.

10 Nov 2013

Pivotal Phase III STARTVerso data shows efficacy of faldaprevir in genotype-1 infected HCV patients

Boehringer Ingelheim today announced new data from its Phase III clinical trial programme, STARTVerso, which evaluates faldaprevir in combination with pegylated interferon and ribavirin (PegIFN/RBV).

5 Nov 2013

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

ARIAD Pharmaceuticals, Inc. today announced that it is temporarily suspending the marketing and commercial distribution of Iclusig® (ponatinib), a treatment for patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL), in the United States, while it continues to negotiate updates to the U.S. prescribing information for Iclusig and implementation of a risk mitigation strategy.

31 Oct 2013

Researchers find more accurate method to screen for meningococcal infection

Researchers from the University of Missouri School of Medicine have found a more accurate method to screen for bacterial meningococcal infection in its early stages, when it's hardest to detect. According to the researchers, the method for diagnosis could save lives by getting patients treatment earlier, when the infection is most treatable.

31 Oct 2013

Once-daily prescription medicine for COPD now available throughout the U.S.

GlaxoSmithKline plc and Theravance, Inc. today announced that BREO ELLIPTA, a once-daily prescription medicine for chronic obstructive pulmonary disease, is now available to pharmacies throughout the U.S.

30 Oct 2013

High-definition transcranial direct current stimulation helps treat pain in fibromyalgia patients

Imagine significantly reducing a persistent migraine or fibromyalgia by a visit to a doctor who delivers low doses of electricity to the brain.

30 Oct 2013

Houston Methodist physicians provide tips for training, protecting the entire body

For avid runners, training for the next marathon never stops. While it's important to focus on running faster or farther, Houston Methodist physicians encourage runners to expand their training regimen and are providing the following tips for training and protecting the entire body.

29 Oct 2013

Phase 3 study shows STELARA inhibits structural damage in patients with active psoriatic arthritis

New findings from two integrated Phase 3 Janssen Research & Development, LLC (Janssen)-sponsored studies showed treatment with STELARA- (ustekinumab) resulted in significantly greater inhibition of structural damage in patients with active psoriatic arthritis compared with placebo.

29 Oct 2013

Study: Headache is not a sign of lupus activity

Headache is common among patients with system lupus erythematosus according to new research published in Arthritis & Rheumatism, a journal of the American College of Rheumatology.

28 Oct 2013

Will Obamacare website be able to transfer Medicaid enrollment data?

Politico raises questions about whether the transfer of Medicaid enrollment data to 36 states participating in the federal exchange will go smoothly Nov. 1 when it's slated to begin. The Los Angeles Times looks at how Ohio Gov. John Kasich's decision to pursue Medicaid expansion in defiance of the right wing of his party may affect his political future.

25 Oct 2013

First Edition: October 24, 2013

Today's headlines include reports that the Obama administration plans to tweak the tax-penalty deadline for signing up for health insurance as well as previews of what might happen when the contractors who built the health law's online insurance marketplace testify today on Capitol Hill.

24 Oct 2013

Rethinking the 1930s attack on malaria may help solve modern day malaria outbreaks

A new University of Texas at Arlington study about the elimination of malaria in the 1930s American South may have significant implications for solving modern day malaria outbreaks in parts of Africa, Central and Latin America, and Asia.

24 Oct 2013

CoLucid signs distribution and supply agreement with ILDONG for Lasmiditan

CoLucid Pharmaceuticals, Inc., and ILDONG Pharmaceutical Co., Ltd., announced today that they have entered into a distribution and supply agreement for Lasmiditan in South Korea and Southeast Asia.

23 Oct 2013

FDA approves SC formulation of Genentech's Actemra for rheumatoid arthritis

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has approved a subcutaneous formulation of Actemra (tocilizumab) for the treatment of adults with moderately to severely active rheumatoid arthritis who have used one or more disease-modifying antirheumatic drugs, such as methotrexate, that did not provide enough relief.

22 Oct 2013

Phase 2b study of JAK3 inhibitor VX-509 shows improvement in people with active RA

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced 12-week results from an ongoing Phase 2b study of VX-509, an investigational oral, selective Janus kinase 3 (JAK3) inhibitor, dosed once or twice daily in people with active rheumatoid arthritis (RA) taking methotrexate

19 Oct 2013

FDA approves Iroko Pharmaceuticals’ ZORVOLEX capsules

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that the U.S. Food and Drug Administration (FDA) has approved ZORVOLEX™ (diclofenac) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the treatment of mild to moderate acute pain in adults. ZORVOLEX was approved at dosage strengths that are 20 percent lower than currently available diclofenac products.

19 Oct 2013

Luden partners with Thompson Square to celebrate "Voices Worth Hearing"

Luden's, the soothing throat drop loved by voices everywhere, today announced a new partnership with Thompson Square, the reigning Academy of Country Music and Country Music Association "Vocal Duo of the Year."

19 Oct 2013

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

The U.S. Food and Drug Administration today approved Opsumit (macitentan), a new drug to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive and debilitating disease that can lead to death or the need for lung transplantation.

19 Oct 2013

Recombinant hormone could REPLACE calcium supplements

Results from the phase III REPLACE trial of recombinant human parathyroid hormone (rhPTH) indicate the treatment can successfully combat the underlying deficit in hypoparathyroidism.

18 Oct 2013

Headache News and Research

Latest Headache News and Research

First generic versions of Aciphex delayed-release tablets get FDA approval for GERD treatment

Aptiom receives FDA approval to treat seizures associated with epilepsy

Pivotal Phase III STARTVerso data shows efficacy of faldaprevir in genotype-1 infected HCV patients

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

Researchers find more accurate method to screen for meningococcal infection

Once-daily prescription medicine for COPD now available throughout the U.S.

High-definition transcranial direct current stimulation helps treat pain in fibromyalgia patients

Houston Methodist physicians provide tips for training, protecting the entire body

Phase 3 study shows STELARA inhibits structural damage in patients with active psoriatic arthritis

Study: Headache is not a sign of lupus activity

Will Obamacare website be able to transfer Medicaid enrollment data?

First Edition: October 24, 2013

Rethinking the 1930s attack on malaria may help solve modern day malaria outbreaks

CoLucid signs distribution and supply agreement with ILDONG for Lasmiditan

FDA approves SC formulation of Genentech's Actemra for rheumatoid arthritis

Phase 2b study of JAK3 inhibitor VX-509 shows improvement in people with active RA

FDA approves Iroko Pharmaceuticals’ ZORVOLEX capsules

Luden partners with Thompson Square to celebrate "Voices Worth Hearing"

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

Recombinant hormone could REPLACE calcium supplements

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Headache News and Research

Latest Headache News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in